JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
NCT06675422
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus (SLE)
Interventions
DRUG:
JY231 injection
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China